Newleos Therapeutics is making its debut with $93.5 million aimed at developing safer and more effective neuroscience ...

"The ongoing complexities of COVID-19 require multiple lines of defence," said Bill Anderson, CEO of Roche Pharmaceuticals. “By joining forces with Atea, we hope to offer an additional treatment ...

Roche Holding AG is a research healthcare company. It operates through the Pharmaceuticals and Diagnostics segments. The Pharmaceutical division comprises the business segments, such as Roche ...